These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20663403)

  • 21. Systemic lupus erythematosus-associated neutrophilic dermatosis manifesting as an acneiform eruption and foot pain.
    Hannah CE; Moye MS; Wanat KA; Liu V
    Clin Exp Dermatol; 2019 Oct; 44(7):801-803. PubMed ID: 30610768
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug induced linear IgA bullous dermatosis].
    Montagnac R; Reguiaï Z; Méhaut S; Bressieux JM; Schillinger F
    Nephrologie; 2003; 24(6):287-92. PubMed ID: 14584295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of lupus nephritis.
    Kaplan D; Ginzler E
    Proc Clin Dial Transplant Forum; 1974; (4):86-9. PubMed ID: 4468428
    [No Abstract]   [Full Text] [Related]  

  • 24. [Linear IgA bullous dermatosis: a review].
    Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Images of the month. What is your diagnosis? An acutely painful and recurrent macule].
    Henry F
    Rev Med Liege; 1999 Jul; 54(7):632-3. PubMed ID: 10495689
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral vancomycin-induced linear IgA bullous dermatosis.
    Belhareth K; Soua Y; Hraeich A; Fredj NB; Badreddine S; Ali HB; Zili J
    Indian J Dermatol Venereol Leprol; 2019; 85(6):621-622. PubMed ID: 31571615
    [No Abstract]   [Full Text] [Related]  

  • 28. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
    Pusongchai T; Jungthirapanich J; Khositseth S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin-associated linear IgA bullous dermatosis.
    Nousari HC; Costarangos C; Anhalt GJ
    Ann Intern Med; 1998 Sep; 129(6):507-8. PubMed ID: 9735094
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical corticosteroids for skin disorders in infants and children.
    Keipert JA
    Aust Fam Physician; 1985 May; 14(5):392-7. PubMed ID: 3160326
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic lupus erythematosus presenting as a bullous eruption in a child.
    Kettler AH; Bean SF; Duffy JO; Gammon WR
    Arch Dermatol; 1988 Jul; 124(7):1083-7. PubMed ID: 3291780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
    Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
    Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lupus erythematosus-associated neutrophilic dermatosis--an underrecognized neutrophilic dermatosis in patients with systemic lupus erythematosus.
    Larson AR; Granter SR
    Hum Pathol; 2014 Mar; 45(3):598-605. PubMed ID: 24457080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases.
    Seneschal J; Milpied B; Taieb A
    Chem Immunol Allergy; 2012; 97():203-16. PubMed ID: 22613864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced systemic lupus erythematosus in a child after 3 years of treatment with carbamazepine.
    Molina-Ruiz AM; Lasanta B; Barcia A; Pérez-Vega E; Requena L
    Australas J Dermatol; 2017 Feb; 58(1):e20-e22. PubMed ID: 26424435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug eruptions from mesna. After cyclophosphamide treatment of patients with systemic lupus erythematosus and dermatomyositis.
    Zonzits E; Aberer W; Tappeiner G
    Arch Dermatol; 1992 Jan; 128(1):80-2. PubMed ID: 1531405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Strontium ranelate-induced DRESS syndrome].
    Le Merlouette M; Adamski H; Dinulescu M; Le Gall F; Colin F; Grimaud H; Chevrant-Breton J
    Ann Dermatol Venereol; 2011 Feb; 138(2):124-8. PubMed ID: 21333824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of systemic lupus erythematosus using a combination of cyclophosphamide (Endoxan) and corticosteroids].
    Muhl E; Adorf A
    Med Welt; 1974 Mar; 25(9):366-7. PubMed ID: 4818893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.